In order to determine the model robustness for predicting prognosis of HCC patient after tumor resection, we finally resorted to ROC curve analyses by individually using the expression of each marker (DUOX1, GLS2, FBP1) (Fig. 2). This evidence concerns the gene FBP1 and hepatocellular carcinoma.